DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rd6gkt/nintedanib_compr) has announced the addition of the "Nintedanib - Comprehensive patent search" report to their offering.
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.
Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.
Pipeline Developer features:
- Comprehensive patent searching, covering the world's key territories (see 'search coverage' below)
- Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified'below)
- Patent identification, categorisation and interpretation
- Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims
- Manual filtration of patents not relevant to generic development
- Updated on a monthly basis, including changes to patent families, statuses, and litigation
- Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers
Search coverage:
Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries.
For more information visit http://www.researchandmarkets.com/research/rd6gkt/nintedanib_compr